| Tag | Content |
|---|
EnhancerAtlas ID | HS117-01263 |
Organism | Homo sapiens |
Tissue/cell | LHCN-M2 |
Coordinate | chr11:35103380-35105430 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr11:35103734-35103755 | AAAATAAAAGCAAAACAGAAA | - | 6.03 | | IRF1 | MA0050.2 | chr11:35103728-35103749 | AAAATAAAAATAAAAGCAAAA | - | 6.81 | | Nr2f6(var.2) | MA0728.1 | chr11:35103502-35103517 | GAGGTCAGGAGTTCA | + | 6.22 | | ZBTB18 | MA0698.1 | chr11:35103828-35103841 | CTTCCAGATGTGC | + | 6.17 | | ZNF263 | MA0528.1 | chr11:35103412-35103433 | TCCCTTTTCACCTCCTCCTTT | - | 6.31 |
|
| | Number of super-enhancer constituents: 19 | ID | Coordinate | Tissue/cell |
| SE_10718 | chr11:35103651-35106244 | CD19_Primary | | SE_11615 | chr11:35103176-35107063 | CD20 | | SE_12205 | chr11:35103452-35106884 | CD3 | | SE_14966 | chr11:35103246-35107086 | CD4_Memory_Primary_7pool | | SE_16067 | chr11:35103332-35106798 | CD4_Naive_Primary_7pool | | SE_16834 | chr11:35103458-35106781 | CD4_Naive_Primary_8pool | | SE_17248 | chr11:35103634-35106575 | CD4p_CD225int_CD127p_Tmem | | SE_18923 | chr11:35103259-35107250 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19832 | chr11:35103417-35107078 | CD4p_CD25-_Il17p_PMAstim_Th17 | | SE_20601 | chr11:35103628-35106266 | CD56 | | SE_22911 | chr11:35103621-35106842 | CD8_primiary | | SE_30479 | chr11:35103583-35110787 | Fetal_Muscle | | SE_36037 | chr11:35103058-35106758 | HMEC | | SE_44354 | chr11:35103454-35106871 | NHDF-Ad | | SE_46152 | chr11:35103257-35106758 | Osteoblasts | | SE_52114 | chr11:35103627-35106397 | Skeletal_Muscle_Myoblast | | SE_56204 | chr11:35103121-35108206 | u87 | | SE_62613 | chr11:35051325-35112817 | Tonsil | | SE_63905 | chr11:35103613-35106477 | HSMM |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH11I035081 | chr11 | 35103199 | 35111026 |
|
Enhancer Sequence | TGGTCAATAT CATGTCTTCT CTCCCTCAAG GCTCCCTTTT CACCTCCTCC TTTTCCTGGC 60
AAAGCAAACA CAACAAACAA AAATCTGCAA GATGCTGGGA GGCCAAGGCA GGTGGATCAC 120
TTGAGGTCAG GAGTTCAAGA CCATTCTGGC CAACATGGTG AAACCCTGTC TCTACTAAAA 180
ATACAAAAAT TAGCCAGGTG TGGTGGTGCG CGCCTGTGAT CCCAGCTACT CGGGAGGCTG 240
AGGCAGGAGA ATCACTTGAA CCTGGGAGGT GGAGCTTGCA GTGAGCCAAG ATTCCACCAC 300
TGCACTCCAG CCTGGGTGAC ACAGTGAGCC TCCACCTCAA AAAAAAAAAA AATAAAAATA 360
AAAGCAAAAC AGAAAAACCT GCAAGATGCC ATAGTGCTCC CTTCTCAACT TCATGGAAAT 420
TCTGAAATAT ATATGGGATT CATTTTTCCT TCCAGATGTG CGATTTGGAG GGTGGAGTGT 480
CAAAGGAAGA GAACTGGGGG AATTCTTGAC CTGGCTGGGC TCTTCTTTGG CCCCAGCTCC 540
CCGTTCATCC TTCACCTCCC TCCCATCCTG GCTGCTCACA TTCCTATGTG GTGAGTTCTG 600
CTCCTCAGCA GTGGAGCAGG GGCTGGACTG GGCAGGGGAG AGTCGCAGGC TCCATGTGTC 660
CAGCCTGCCC TGGTGGACTG ATGGTGTTGC CCAGGAAAGG CGTGCGAGGC CACGGCTTCT 720
GACAGCCGCA ATCTGGAGTT GCTGTTAGGT CTGATTGAAT GATTGACACA CCACAAGCAG 780
AAATCTAGAA CTCCAGAACG GGTCTGGTGG AAGGAGCCAA CTCTGTTTGC AGTTTCCTCT 840
TCTCACCACA GCACAGTGTC GGGTTACCAC GGAGATAGGG AGGAACCTTC TGAGACCTCT 900
CCAATGGTGG GTGGCAGCCA CAGTCAGCCA GGGAGGACTA CACCCAATCC TTGGCTCCGC 960
CCCTCCTCCC ACACCCCAAA AGAAGCCACA CAGCTAGCCA GAGAGGGGCT GCCTCTGGAA 1020
TGCACACCAG GGCTTGTCCA CACACACTCC CCGGCCCTCT GCGCCTCTTT AGGGAGGTTC 1080
CTGCTGCTGG ATCTGCTGCC TTCTTCACCT TGAGAGTGCA TTTATGTAAC AAGAAAACAC 1140
CTGGGTGTTT TCACAGGTAG GAAGAGATTG GCGGCTGAGC TGTTCTCTCA TTTGGATGCA 1200
AGGCTGTGAG ATGGGGCCTC TGTTGGCCTA GAGGTCCCGA GAAATTGGGA GGAGAGGTGC 1260
CAGTAGCAAG CCCCAAGGTC GGGGTTCCTC CTCTAACCTC TCTGTGGGGT GGAGGCATCC 1320
ACACCAAACC TTAAGAGGGA GCAATGGGTC TAACTGCTAA TTCTGAAGGT GAGCAGGCCC 1380
GTTTCCACAT GCCAATGTCA AAATCCAACC ACAGTTTGAC AAGCCTTTGG GAACATCCAG 1440
TAATTACATA ATAGCACTCC CAAACATGAC AAGTGCTTTC ATCTTTACAA AGACTGTCGT 1500
GTTTGTTCTC ACTCTCCTCC CCATATGAGT TGCTTCTCTT TCTTTCCCCT ATTTTGCAGA 1560
TAAGAAGGTG GAGGCTCAGG AAGGTAGAGT GACTTTCTAC TACTAAAGAA CTAGCAGGAA 1620
AGTATTTCAA ATTCAAGTCT CATGACCCTA AATGCAGGGT ATTTCCCAGT GGCTCATGGT 1680
AAATGAGTTC CTTAAAAATG AGCCACGCTG AGGCCTGAAA CTACAGGGCT TACTGATGTG 1740
GCTGCAAGCT GCAGCTCTAA GCCAGAAAGG GGACAAGCTA AGGAGAAGAG GAACCACCTT 1800
TGCACTGGCG GACTTCAGCG TGTCTCACGC ATGCCGAATG TTTACATGTG TTCCCCACTT 1860
GGTATCCATA GCAACTGGCA GAGGTGCAAA AATGCTTCAT TGGTATTTGT AAGAGGATGA 1920
GAAGAAAGCC CTCCAAGATC CTCTTTCTCC CAGTGGGCAG GGCTATTTCC ATCCATGGCT 1980
TCGTGACTTC TCCCAGCAGC CGTTTGGCAT GAGGATTTCA AACAGCAGGG AGCCAGTGAG 2040
TCCACCGGAT 2050
|
